Clinical Trials

NCT IdNCT04833998
TitleHydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine
ConditionHand-foot Syndrome
StudyTypeInterventional
OrganizationInstituto Brasileiro de Controle do Cancer
Sponsor/CollaboratorsInstituto Brasileiro de Controle do Cancer
StatusRecruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • IBCC Oncologia, São Paulo, 03102002 , Brazil
DescriptionHand-foot syndrome (HFS) is a very common adverse event of many chemotherapeutic agents, especially capecitabine. The HFS can considerably interfere patient quality of life (QoL). The current treatments for hand-foot symptoms no have demonstrated 100% efficacy. And, the dose reduction and treatment interruption are recommended for treatment of HFS. It is known that hydration improves the degree of hand-foot syndrome, as it improves moisture retention and maintain hydration, thereby reducing further desquamation and decreasing infection risks. But so far there is no evidence of a cream that improves incidence. Besides that, clinical trials evaluating the use of urea-based moisturizer in patients treated with capecitabine have not shown efficacy in preventing hand-foot syndrome. The purpose of this study is to evaluate the effectiveness of moisturizer based on Thoitaine, Aloe Vera and Calendula compared to placebo in the prevention of SMP of any degree, in patients using Capecitabine.